Brandon Turbeville
November 10, 2012
 |
| Dees Illustration |
In what may prove to be a minor public relations setback for vaccine
pushers like Bill Gates and GlaxoSmithKline, the much touted Mosquirix malaria
vaccine recently rolled out in Africa has been officially demonstrated to be
only 30% effective in babies.
Results from the final-stage trial administered by GSK appeared to demonstrate that the vaccine only provided “modest protection” for babies aged six to 12 weeks, with a reduction in the contraction of the disease by only 30%, a much lower number than what had been touted by those promoting the jab in the industry and the corporate media.
Reuters also reports that for children after the age of six months, a 65% rate was established. For children of five to 17 months old, the researchers claim a protection of around 50%.
Results from the final-stage trial administered by GSK appeared to demonstrate that the vaccine only provided “modest protection” for babies aged six to 12 weeks, with a reduction in the contraction of the disease by only 30%, a much lower number than what had been touted by those promoting the jab in the industry and the corporate media.
Reuters also reports that for children after the age of six months, a 65% rate was established. For children of five to 17 months old, the researchers claim a protection of around 50%.
In response to what Reuters has dubbed a “surprisingly poor result” for the vaccine, Bill Gates stated, “The efficacy came back lower than we had hoped, but developing a vaccine against a parasite is a very hard thing to do.”
Indeed, Gates is correct in suggesting the difficulty for creating a vaccine for a Protozoan, the type of parasite which causes malaria, This is because vaccines are supposedly designed to protect against viruses. Thus, the Mosquirix vaccine enters into the growing science of DNA vaccines – a research field which is expanding but also one in which the science is still very much out in regards to effectiveness, safety, and even possibility.
Nevertheless, GSK has announced that it will not be giving up in the attempt to
develop Mosquirix into a more “effective” vaccine, and will be working with
governments and international groups in order to fund the operation. GSK claims
it does not plan to make a profit from Mosquirix, although it admits that it
will be charging a 5% profit margin on the product. The funding for the
development and rollout, of course, will be coming from the governments and
international groups mentioned above, meaning it is the cash-strapped taxpayer
who must shovel out the cash for yet another eugenics program aimed at poor
Africans.
Interestingly enough, it was Bill Gates himself
who once
stated, “The world today has 6.8 billion people... that's headed up to about
9 billion. Now if we do a really great job on new vaccines, health care,
reproductive health services, we could lower that by perhaps 10 or 15
percent.”
Of course, it bears noting, especially in this context, that the results of the GSK study show only a 30% efficacy rate yet the companies, governments, and international “groups” behind the push are continuing to move forward with plans for yet more vaccination programs whose harmful effects have not been properly studied.
Yet, even the 30% itself is highly suspect considering the fact that there has never been a study proving that vaccines are either safe or effective that itself was not connected to a vaccine maker or pharmaceutical company.[1]
The
fact that the ineffectiveness of the malaria vaccine is being announced openly
by the corporation that created it as well as one of the most notorious vaccine
pushers in the world is striking. With this in mind, one could be led to suppose
that the real percentage of efficacy might be even lower if non-politicized
science were applied to it.Of course, it bears noting, especially in this context, that the results of the GSK study show only a 30% efficacy rate yet the companies, governments, and international “groups” behind the push are continuing to move forward with plans for yet more vaccination programs whose harmful effects have not been properly studied.
Yet, even the 30% itself is highly suspect considering the fact that there has never been a study proving that vaccines are either safe or effective that itself was not connected to a vaccine maker or pharmaceutical company.[1]
In the end, the real goal of such vaccine programs as those currently being funded in Africa is a eugenics-based, population reduction philosophy that permeates governments, corporations, NGO’s, and academia. Unfortunately, it is for this reason that open the open failure of the malaria vaccine will do little to deter the expense of more money, more time, and more propaganda being spent toward the goal of vaccinating and reducing the vast majority of the population of Africa.
[1] Flu and Flu Vaccines: What’s Coming Through That Needle. Dr. Sherri Tenpenny.
Part 1 - https://www.youtube.com/watch?v=uCqHeUDdX_4
Part 2 - https://www.youtube.com/watch?v=wtfoxXuA5rcn
Read other articles by Brandon Turbeville here.
Brandon Turbeville is an author out of Mullins, South Carolina. He has a Bachelor's Degree from Francis Marion University and is the author of three books, Codex Alimentarius -- The End of Health Freedom, 7 Real Conspiracies, and Five Sense Solutions and Dispatches From a Dissident. Turbeville has published over 175 articles dealing on a wide variety of subjects including health, economics, government corruption, and civil liberties. Brandon Turbeville's podcast Truth on The Tracks can be found every Monday night 9 pm EST at UCYTV. He is available for radio and TV interviews. Please contact activistpost (at) gmail.com.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.